PHOTODYNAMIC THERAPY USING TOPICALLY APPLIED DIHEMATOPORPHYRIN ETHER IN THE TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA

Citation
Bj. Monk et al., PHOTODYNAMIC THERAPY USING TOPICALLY APPLIED DIHEMATOPORPHYRIN ETHER IN THE TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA, Gynecologic oncology, 64(1), 1997, pp. 70-75
Citations number
30
Categorie Soggetti
Oncology,"Obsetric & Gynecology
Journal title
ISSN journal
00908258
Volume
64
Issue
1
Year of publication
1997
Pages
70 - 75
Database
ISI
SICI code
0090-8258(1997)64:1<70:PTUTAD>2.0.ZU;2-Y
Abstract
Objective: To perform a phase I study of topically applied dihematopor phyrin ether (DHE) in the photodynamic treatment (PDT) of cervical int raepithelial neoplasia (CIN) using fixed DHE doses and application sch edules, and a variable dose of 630 nm red light delivered by an argon- pumped dye laser. Methods: Between February 1993 and April 1994, 24 no npregnant women with a histologic diagnosis of CIN were enrolled, All patients had lesions involving at least 25% of the cervix that were co lposcopically visible. Using a cervical cap, 2 ml of a 1% solution of DHE (Photofrin) in a 4% Azone and isopropyl alcohol vehicle were appli ed to the cenix 24 hr prior to PDT. An argon-pumped dye laser providin g light at 630 nm was then used to perform PDT. Light was coupled into a 400-mu m silica fiber optic terminating in a microlens which focuse d the laser radiation onto a circular held of uniform light intensity perpendicular to the tissue. The entire ectocervix was treated in a si ngle held including a margin of 3-5 mm of normal cervix. Using a const ant power density (150 mW/cm(2)) to avoid thermal injury, the PDT ener gy was increased every 4 patients in a phase I fashion (40, 60, 80, 10 0, 120, and 140 J/cm(2)). Results: Thirteen patients with CIN I, 7 pat ients with CIN II, and 4 patients with CIN III were treated. The maxim al energy density was well tolerated. Toxicity was minimal with no pat ients experiencing local necrosis, sloughing, or scarring; however, a mild vaginal discharge was noted in several patients. Systemic effects were absent. After 12 months of follow-up at 3-month intervals, 22 pa tients are evaluable of whom 15 (68%) are disease free. One patient wa s lost to follow-up and in another the cervical cap was dislodged. Fou r of the 7 failures or recurrences occurred at energy densities of 80 J/cm(2) or less, while 8 of 11 (73%) patients were treated successfull y with PDT at an energy density of 100 to 140 J/cm(2). Conclusions: PD T with DHE and an argon-pumped dye laser at 630-nm wavelength deliveri ng an energy density of 140 J/cm(2) is safe and effective in treating GIN. Phase II studies using PDT at the prescribed application schedule and dose are indicated. (C) 1997 Academic Press